Ginkgo BioworksDNA

紐約證券 · USD
13.14
+0.26
(+2.02%)
收盤 08/01 03:59 (UTC+8)
盤後 
13.10 
13.10 
(-0.30%)
08/01 03:59 (UTC+8)

財務數據

損益表

loading
載入中...
icon
  • 0.98
  • 0.81
  • 0.81
  • 0.55
  • 0.35
  • 0.38
  • 0.56
  • 0.89
  • 0.44
  • 0.48
icon
  • 48.02
  • -17.89
  • -0.17
  • -31.20
  • -37.30
  • 9.18
  • 48.13
  • 58.43
  • -50.76
  • 10.20
  • icon
    營業收入(億)
  • icon
    季增長率(%)
單位:美元千元
年季
2025/Q1
2024/Q4
2024/Q3
2024/Q2
2024/Q1
2023/Q4
2023/Q3
2023/Q2
2023/Q1
2022/Q4
營業收入淨額
48,318
43,847
89,046
56,206
37,944
34,755
55,430
80,568
80,702
98,285
營業成本
12,0479,62212,00313,7219,2026,6116,92318,09622,37530,218
營業毛利
36,271
34,225
77,043
42,485
28,742
28,144
48,507
62,472
58,327
68,067
營業費用
-----206,261334,900246,623274,072298,931
研發費用
70,92376,37777,006134,221136,457117,038156,662144,282162,639177,548
推銷及管理費用
49,04357,29752,29266,28570,28789,22382,028102,341111,433121,383
非經常性項目費用
5,2734,1572,94964,924--96,210---
其他營業費用
----------
營業利益
-88,968
-103,606
-55,204
-222,945
-178,002
-178,117
-286,393
-184,151
-215,745
-230,864
其他收入及費用
-1,901-4,159-1,5745,95412,122-32,563-16,52010,97012,30733,119
利息費用
-94---93---106
稅前純益
-90,869
-107,859
-56,778
-216,991
-165,880
-211,892
-302,913
-173,248
-204,887
-187,848
所得稅
88-325-37519031-198-226782-14,770
稅後純益
-90,957
-107,534
-56,403
-217,181
-165,911
-211,694
-302,891
-173,315
-204,969
-175,468
基本每股稅後盈餘(元)
-1.68-2.00-1.08-0.11-0.08--0.16-0.09-0.110.00
稀釋每股稅後盈餘(元)
-1.68-1.96-0.98-0.11-0.08-0.11-0.15-0.09-0.11-0.06
基本平均股數(千股)
54241.0053814.0052240.002054801.002004458.00-1950800.001933437.001914963.0074198064.00
稀釋平均股數(千股)
54241.0053814.0052246.002055024.002005334.00-1950800.001933437.001916637.0074264380.00
還原基本每股稅後盈餘(元)
-1.68-2.00-1.08-4.40-3.31--6.21-3.60-4.40-0.09
還原稀釋每股稅後盈餘(元)
-1.68-1.96-0.98-4.28-3.32-4.28-6.09-3.60-4.40-2.60
還原基本平均股數(千股)
54,24153,81452,24051,37050,111-48,77048,33547,8741,854,951
還原稀釋平均股數(千股)
54,24153,81452,24651,37550,133-48,77048,33547,9151,856,609
EBITDA(千元)
-75,503-92,113-39,609-199,661-153,011-197,915-281,853-155,027-185,929-172,594

大家都在看

HOT